{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:38:14Z","timestamp":1787168294423,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T00:00:00Z","timestamp":1606089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T00:00:00Z","timestamp":1606089600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s00431-020-03880-5","type":"journal-article","created":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T02:02:49Z","timestamp":1606096969000},"page":"1293-1298","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Intestinal microbiome: a new target for chalaziosis treatment in children?"],"prefix":"10.1007","volume":"180","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1950-0200","authenticated-orcid":false,"given":"Mariaelena","family":"Filippelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7663-8874","authenticated-orcid":false,"given":"Roberto","family":"dell\u2019Omo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Amoruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Paiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Pane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6044-7486","authenticated-orcid":false,"given":"Pasquale","family":"Napolitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7105-6392","authenticated-orcid":false,"given":"Silvia","family":"Bartollino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8477-6188","authenticated-orcid":false,"given":"Ciro","family":"Costagliola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,23]]},"reference":[{"issue":"3","key":"3880_CR1","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.jfda.2018.01.002","volume":"26","author":"R George Kerry","year":"2018","unstructured":"George Kerry R, Patra JK, Gouda S, Park Y, Shin HS, Das G (2018) Benefaction of probiotics for human health: a review. J Food Drug Anal 26(3):927\u2013939. https:\/\/doi.org\/10.1016\/j.jfda.2018.01.002","journal-title":"J Food Drug Anal"},{"key":"3880_CR2","unstructured":"Food and Agriculture Organization and World Health Organization Expert Consultation (2001) Evaluation of health and nutritional properties of powder milk and live lactic acid bacteria. C\u00f3rdoba, Argentina: Food and Agriculture Organization of the United Nations and World Health Organization. Available from:.http:\/\/www.fao.org\/3\/a-a0512e.pdf Accessed: 29 March 2020"},{"issue":"2","key":"3880_CR3","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1136\/gutjnl-2014-308514","volume":"64","author":"MH McLean","year":"2015","unstructured":"McLean MH, Dieguez D Jr, Miller LM, Young HA (2015) Does the microbiota play a role in the pathogenesis of autoimmune diseases? Gut. 64(2):332\u2013341. https:\/\/doi.org\/10.1136\/gutjnl-2014-308514","journal-title":"Gut."},{"issue":"1","key":"3880_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/art.39259","volume":"68","author":"JU Scher","year":"2016","unstructured":"Scher JU, Littman DR, Abramson SB (2016) Microbiome in inflammatory arthritis and human rheumatic diseases. Arthritis Rheum 68(1):35\u201345. https:\/\/doi.org\/10.1002\/art.39259","journal-title":"Arthritis Rheum"},{"key":"3880_CR5","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.trsl.2016.07.016","volume":"179","author":"J Ochoa-Reparaz","year":"2017","unstructured":"Ochoa-Reparaz J, Kasper LH (2017) The influence of gut-derived CD39 regulatory T cells in CNS demyelinating disease. Transl Res 179:126\u2013138. https:\/\/doi.org\/10.1016\/j.trsl.2016.07.016","journal-title":"Transl Res"},{"issue":"4","key":"3880_CR6","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s12088-018-0746-9","volume":"58","author":"S Kalyana Chakravarthy","year":"2018","unstructured":"Kalyana Chakravarthy S, Jayasudha R, Sai Prashanthi G, Ali MH, Sharma S, Tyagi M, Shivaji S (2018) Dysbiosis in the gut bacterial microbiome of patients with uveitis, an inflammatory disease of the eye. Indian J Microbiol 58(4):457\u2013469. https:\/\/doi.org\/10.1007\/s12088-018-0746-9","journal-title":"Indian J Microbiol"},{"issue":"3","key":"3880_CR7","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s00417-007-0682-6","volume":"246","author":"A Iovieno","year":"2008","unstructured":"Iovieno A, Lambiase A, Sacchetti M, Stampachiacchiere B, Micera A, Bonini S (2008) Preliminary evidence of the efficacy of probiotic eye-drop treatment in patients with vernal keratoconjunctivitis. Graefes Arch Clin Exp Ophthalmol 246(3):435\u2013441. https:\/\/doi.org\/10.1007\/s00417-007-0682-6","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"3880_CR8","doi-asserted-by":"publisher","first-page":"E88","DOI":"10.3390\/antibiotics8030088","volume":"8","author":"A Tavakoli","year":"2019","unstructured":"Tavakoli A, Flanagan JL (2019) The case for a more holistic approach to dry eye disease: is it time to move beyond antibiotics? Antibiotics (Basel) 8(3):E88. https:\/\/doi.org\/10.3390\/antibiotics8030088","journal-title":"Antibiotics (Basel)"},{"issue":"3","key":"3880_CR9","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/ICU.0000000000000465","volume":"29","author":"P Lin","year":"2018","unstructured":"Lin P (2018) The role of intestinal microbiome in ocular inflammatory disease. Curr Opin Ophthalmol 29(3):261\u2013266. https:\/\/doi.org\/10.1097\/ICU.0000000000000465","journal-title":"Curr Opin Ophthalmol"},{"issue":"6","key":"3880_CR10","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1177\/1535370218813616","volume":"244","author":"AD Baim","year":"2019","unstructured":"Baim AD, Movahedan A, Farooq AV, Skondra D (2019) The microbiome and ophthalmic disease. Exp Biol Med (Maywood) 244(6):419\u2013429. https:\/\/doi.org\/10.1177\/1535370218813616","journal-title":"Exp Biol Med (Maywood)"},{"issue":"3","key":"3880_CR11","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.jtos.2019.05.006","volume":"17","author":"KM Cavuoto","year":"2019","unstructured":"Cavuoto KM, Banerjee S, Galor A (2019) Relationship between the microbiome and ocular health. Ocul Surf 17(3):384\u2013392. https:\/\/doi.org\/10.1016\/j.jtos.2019.05.006","journal-title":"Ocul Surf"},{"issue":"3","key":"3880_CR12","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/ceo.13493","volume":"47","author":"P Lin","year":"2019","unstructured":"Lin P (2019) Importance of the intestinal microbiota in ocular inflammatory diseases: a review. Clin Exp Ophthalmol 47(3):418\u2013422. https:\/\/doi.org\/10.1111\/ceo.13493","journal-title":"Clin Exp Ophthalmol"},{"issue":"5","key":"3880_CR13","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1097\/MOP.0000000000000808","volume":"31","author":"N Sansotta","year":"2019","unstructured":"Sansotta N, Peroni DG, Romano S, Rugiano A, Vuilleumier P, Baviera G, Italian Society of Pediatric Allergy, Immunology (SIAIP), Microbiota Committee, Italy (2019) The good bugs: the use of probiotics in pediatrics. Curr Opin Pediatr 31(5):661\u2013669. https:\/\/doi.org\/10.1097\/MOP.0000000000000808","journal-title":"Curr Opin Pediatr"},{"issue":"1","key":"3880_CR14","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12886-019-1118-x","volume":"19","author":"BA Sklar","year":"2019","unstructured":"Sklar BA, Gervasio KA, Leng S, Ghosh A, Chari A, Wu AY (2019) Management and outcomes of proteasome inhibitor associated chalazia and blepharitis: a case series. BMC Ophthalmol 19(1):110. https:\/\/doi.org\/10.1186\/s12886-019-1118-x","journal-title":"BMC Ophthalmol"},{"issue":"12","key":"3880_CR15","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1097\/ICO.0b013e31821de36f","volume":"30","author":"AY Nemet","year":"2011","unstructured":"Nemet AY, Vinker S, Kaiserman I (2011) Associated morbidity of chalazia. Cornea. 30(12):1376\u20131381. https:\/\/doi.org\/10.1097\/ICO.0b013e31821de36f","journal-title":"Cornea."},{"issue":"2","key":"3880_CR16","doi-asserted-by":"publisher","first-page":"159","DOI":"10.5301\/ejo.5000341","volume":"24","author":"JC Yam","year":"2014","unstructured":"Yam JC, Tang BS, Chan TM, Cheng AC (2014) Ocular demodicidosis as a risk factor of adult recurrent chalazion. Eur J Ophthalmol 24(2):159\u2013163. https:\/\/doi.org\/10.5301\/ejo.5000341","journal-title":"Eur J Ophthalmol"},{"issue":"3","key":"3880_CR17","first-page":"183","volume":"15","author":"E Bonifazi","year":"2005","unstructured":"Bonifazi E (2005) Linear chalaziosis. Eur J Pediatr Dermatol 15(3):183","journal-title":"Eur J Pediatr Dermatol"},{"issue":"3","key":"3880_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1442-9071.2008.01714.x","volume":"36","author":"CG Burkhart","year":"2008","unstructured":"Burkhart CG, Burkhart CN (2008) Similar to acne vulgaris, bacteria may produce the biological glue that causes plugging of the meibomian gland leading to chalazions. Clin Exp Ophthalmol 36(3):295. https:\/\/doi.org\/10.1111\/j.1442-9071.2008.01714.x","journal-title":"Clin Exp Ophthalmol"},{"issue":"3","key":"3880_CR19","first-page":"63","volume":"6","author":"M Malekahmadi","year":"2017","unstructured":"Malekahmadi M, Farrahi F, Tajdini A (2017) Serum vitamin a levels in patients with chalazion. Med Hypothesis Discov Innov Ophthalmol 6(3):63\u201366","journal-title":"Med Hypothesis Discov Innov Ophthalmol"},{"issue":"3","key":"3880_CR20","first-page":"325","volume":"89","author":"LJ Lu","year":"2016","unstructured":"Lu LJ, Liu J (2016) Human microbiota and ophthalmic disease. Yale J Biol Med 89(3):325\u2013330","journal-title":"Yale J Biol Med"},{"issue":"6","key":"3880_CR21","first-page":"435","volume":"3","author":"AL Giacomin","year":"2016","unstructured":"Giacomin AL (2016) Infective and inflammatory eyelid disorders: conventional and unconventional therapies to maintain eye health and avoid lid surgery. EC Ophthalmology 3(6):435\u2013445","journal-title":"EC Ophthalmology"},{"issue":"1","key":"3880_CR22","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/pr.2013.66","volume":"74","author":"K Weimer","year":"2013","unstructured":"Weimer K, Gulewitsch MD, Schlarb AA, Schwille-Kiuntke J, Klosterhalfen S, Enck P (2013) Placebo effects in children: a review. Pediatr Res 74(1):96\u2013102. https:\/\/doi.org\/10.1038\/pr.2013.66","journal-title":"Pediatr Res"},{"key":"3880_CR23","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1111\/cmi.12308","volume":"16","author":"C Petersen","year":"2014","unstructured":"Petersen C, Round JL (2014) Defining dysbiosis and its influence on host immunity and disease. Cell Microbiol 16:1024\u20131033. https:\/\/doi.org\/10.1111\/cmi.12308","journal-title":"Cell Microbiol"},{"issue":"1","key":"3880_CR24","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s40168-018-0603-4","volume":"6","author":"JD Forbes","year":"2018","unstructured":"Forbes JD, Chen CY, Knox NC, Marrie RA, El-Gabalawy H, de Kievit T, Alfa M, Bernstein CN, Van Domselaar G (2018) A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist? Microbiome. 6(1):221. https:\/\/doi.org\/10.1186\/s40168-018-0603-4","journal-title":"Microbiome."},{"issue":"5","key":"3880_CR25","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1177\/112067210901900504","volume":"19","author":"A Iovieno","year":"2009","unstructured":"Iovieno A, Lambiase A, Micera A, Stampachiacchiere B, Sgrulletta R, Bonini S (2009) In vivo characterization of doxycycline effects on tear metalloproteinases in patients with chronic blepharitis. Eur J Ophthalmol 19(5):708\u2013716. https:\/\/doi.org\/10.1177\/112067210901900504","journal-title":"Eur J Ophthalmol"},{"issue":"4","key":"3880_CR26","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1167\/iovs.10-6997g","volume":"52","author":"G Geerling","year":"2011","unstructured":"Geerling G, Tauber J, Baudouin C, Goto E, Matsumoto Y, O'Brien T, Rolando M, Tsubota K, Nichols KK (2011) The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci 52(4):2050\u20132064. https:\/\/doi.org\/10.1167\/iovs.10-6997g","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"19","key":"3880_CR27","doi-asserted-by":"publisher","first-page":"30348","DOI":"10.1016\/j.jtos.2019.10.006","volume":"S1542-0124","author":"CM Trujillo-Vargas","year":"2019","unstructured":"Trujillo-Vargas CM, Schaefer L, Alam J, Pflugfelder SC, Britton RA, de Paiva CS (2019) The gut \u2013eye-lacrimal gland-micobiome axis in Sjogren syndrome. Ocul Surf S1542-0124(19):30348\u201330349. https:\/\/doi.org\/10.1016\/j.jtos.2019.10.006","journal-title":"Ocul Surf"},{"issue":"11","key":"3880_CR28","doi-asserted-by":"publisher","first-page":"4593","DOI":"10.1167\/iovs.17-22119","volume":"58","author":"A Kugadas","year":"2017","unstructured":"Kugadas A, Wright Q, Geddes-McAlister J, Gadjeva M (2017) Role of microbiota in strengthening ocular mucosal barrier function through secretory IgA. Invest Ophthalmol Vis Sci 58(11):4593\u20134600. https:\/\/doi.org\/10.1167\/iovs.17-22119","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"3880_CR29","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1358\/dot.2020.56.3.3079409","volume":"56","author":"M Rizk","year":"2020","unstructured":"Rizk M, Tuzmen S (2020) MicroRNAs and microbiota: is there a cross talk? Drugs Today 56(3):211\u2013226. https:\/\/doi.org\/10.1358\/dot.2020.56.3.3079409","journal-title":"Drugs Today"},{"key":"3880_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40246-020-00257-5","volume":"14","author":"A Nayyar","year":"2020","unstructured":"Nayyar A, Gindina S, Barron A, Hu Y, Danias J (2020) Do epigenetic changes caused by commensal microbiota contribute to development of ocular disease? A review of evidence. Hum Genomics 14:11. https:\/\/doi.org\/10.1186\/s40246-020-00257-5","journal-title":"Hum Genomics"},{"issue":"2","key":"3880_CR31","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1167\/iovs.17-23643","volume":"59","author":"FH Verhagen","year":"2018","unstructured":"Verhagen FH, Bekker CPJ, Rossato M, Hiddingh S, de Vries L, Devaprasad A, Pandit A, Ossewaarde-van Norel J, ten Dam N, Moret-Pot MCA, Imhof SM, de Boer JH, Radstake TRDJ, Kuiper JJW (2018) A disease-associated microRNA cluster links inflammatory pathways and an altered composition of leukocyte subsets to noninfectious uveitis. Invest Ophthalmol Vis Sci 59(2):878\u2013888. https:\/\/doi.org\/10.1167\/iovs.17-23643","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3880_CR32","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1086\/320518","volume":"32","author":"MI Alvarez-Olmos","year":"2001","unstructured":"Alvarez-Olmos MI, Oberhelman RA (2001) Probiotic agents and infectious diseases: a modern perspective on a traditional therapy. Clin Infect Dis 32:1567\u20131576. https:\/\/doi.org\/10.1086\/320518","journal-title":"Clin Infect Dis"},{"issue":"2","key":"3880_CR33","doi-asserted-by":"publisher","first-page":"926","DOI":"10.3892\/etm.2019.7678","volume":"18","author":"E Rusu","year":"2019","unstructured":"Rusu E, Enache G, Cursaru R et al (2019) Prebiotics and probiotics in atopic dermatitis. Exp Ther Med 18(2):926\u2013931. https:\/\/doi.org\/10.3892\/etm.2019.7678","journal-title":"Exp Ther Med"},{"key":"3880_CR34","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1542\/peds.2010-2548","volume":"126","author":"DW Thomas","year":"2010","unstructured":"Thomas DW, Greer FR, Committee on Nutrition; Section on Gastroenterology, Hepatology, and Nutrition (2010) Clinical report\u2014probiotics and prebiotics in pediatrics. Pediatrics 126:1217\u20131231. https:\/\/doi.org\/10.1542\/peds.2010-2548","journal-title":"Pediatrics"},{"issue":"8","key":"3880_CR35","doi-asserted-by":"publisher","first-page":"5408","DOI":"10.1167\/iovs.10-6939","volume":"52","author":"Q Dong","year":"2011","unstructured":"Dong Q, Brulc JM, Iovieno A, Bates B, Garoutte A, Miller D, Revanna KV, Gao X, Antonopoulos DA, Slepak VZ, Shestopalov VI (2011) Diversity of bacteria at healthy human conjunctiva. Invest Ophthalmol Vis Sci 52(8):5408\u20135413. https:\/\/doi.org\/10.1167\/iovs.10-6939","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3880_CR36","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.2147\/OPTH.S166547","volume":"12","author":"KM Cavuoto","year":"2018","unstructured":"Cavuoto KM, Mendez R, Miller D, Galor A, Banerjee S (2018) Effect of clinical parameters on the ocular surface microbiome in children and adults. Clin Ophthalmol 12:1189\u20131197. https:\/\/doi.org\/10.2147\/OPTH.S166547","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"3880_CR37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1167\/tvst.7.6.16","volume":"7","author":"KM Cavuoto","year":"2018","unstructured":"Cavuoto KM, Banerjee S, Miller D, Galor A (2018) Composition and comparison of the ocular surface microbiome in infants and older children. Transl Vis Sci Technol 7(6):16. https:\/\/doi.org\/10.1167\/tvst.7.6.16","journal-title":"Transl Vis Sci Technol"},{"issue":"1","key":"3880_CR38","doi-asserted-by":"publisher","first-page":"9880","DOI":"10.1038\/s41598-017-10494-9","volume":"7","author":"J Ozkan","year":"2017","unstructured":"Ozkan J, Nielsen S, Diez-Vives C, Coroneo M, Thomas T, Willcox M (2017) Temporal stability and composition of the ocular surface microbiome. Sci Rep 7(1):9880. https:\/\/doi.org\/10.1038\/s41598-017-10494-9","journal-title":"Sci Rep"},{"key":"3880_CR39","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jtos.2016.04.004","volume":"3","author":"A Kugadas","year":"2016","unstructured":"Kugadas A, Gadjeva M (2016) Impact of microbiome on ocular health. Ocul Surf 3:342\u2013349. https:\/\/doi.org\/10.1016\/j.jtos.2016.04.004","journal-title":"Ocul Surf"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-020-03880-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00431-020-03880-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-020-03880-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T17:09:52Z","timestamp":1615223392000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00431-020-03880-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,23]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["3880"],"URL":"https:\/\/doi.org\/10.1007\/s00431-020-03880-5","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,23]]},"assertion":[{"value":"26 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Angela Amoruso and Marco Pane are part of PROBIOTICAL RESEARCH Srl, R&D Department. The other authors have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was obtained from the TSC of the Department of Medicine and Health Sciences \u201cV. Tiberio\u201d of Molise University, Campobasso, Italy, and written informed consent was obtained from the parents of all children, in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from all study participants and their parents prior to participation.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Obtained.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"N\/A.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}